News & Reports

Have some news you want to share with the Oregon Bio community?  Fill out our submission form.

Biotech Summit Helps Set Course for 2020

Oregon Bioscience Association held the Biotech Summit on Oct. 28, 2019, aiming to create substantive economic development and policy goals for the coming years.  Oregon’s bioscience industry, comprising more than 800 companies, labs, research institutions and supply chain firms, promotes public policies fostering job creation, company recruitment, innovation and health access, Oregon Bio’s advocacy platform comprises four key elements: 

Accelerate and Improve Oregon’s Environment for Biotechnology and Life Science Companies 
Foster Collaboration Between Industry Experts and Government Leaders 
Support Expansion of a Highly-Skilled, Diverse Workforce 
Maintain Access and Encourage Adherence to Health […]

January 7, 2020 |

Oregon Bio Members Invited to JPM Reception

We are very excited to share that Oregon Bioscience Association and Catalyze are hosting an invitation-only Pacific NW Networking Reception from 4-7 p.m. on Jan. 14, 2020, at the 38th JP Morgan Healthcare Conference in San Francisco.

While the JP Morgan Conference is itself an exclusive event, it has spawned a global hub for healthcare investment. Including our reception, there are many opportunities to connect, network, hold meetings and create partnerships through the many ancillary events that week […]

December 19, 2019 |

CAI Announces Succession Plan: Mike Martin is CAI’s Next CEO

CAI announced that Mike Martin, VP Strategy and Development, has been named to succeed Bob Chew in January 2022.  Mike Martin will assume the role of CEO in January 2022, while Bob Chew will continue to serve as Chairman of the Board.  Mike will work with Bob and the Board of Directors to lead strategy and direction for CAI.

Mike joined CAI in 2018, diving right in leading our program and project management vertical market.  He gained immediate exposure to our […]

December 13, 2019 |

Be Known by the Company You Keep: Your Preview to Oregon Bio’s 2020 Sponsor Prospectus

As you are preparing your 2020 marketing budget, we encourage you to consider Oregon Bioscience Association in your vision for the new year. Oregon Bio, Oregon and SW Washington’s bioscience organization, is planning numerous events around the region.

Supporting Oregon Bio events is an extremely effective way to gain brand visibility and make valuable connections, while also supporting our region’s growing bioscience community. Event sponsorship benefits often include marketing space at events, logo presence, complimentary event registrations, and more. You can […]


For makers, manufacturers, project managers, managers and data analysts, making time for training and upskilling employees and leaders could be a key competitive advantage in 2020

Releasing its industry-honed training and certificate calendar, Oregon Bioscience Association has scheduled more than 20 classes in the first half of 2020. The professional development-track sessions and a combination certificate program highlight process control and improvement, regulatory and compliance updates, Lean Six Sigma methods, ISO 13485:2016 standardization, high performance teamwork, communications, data analysis, […]

December 4, 2019 |

Skanska works with Oregon Health Authority as OHA provides 8,000 opioid overdose reversal safety kits to businesses around Oregon

Oregon Bio member Skanska in Oregon and Southwest Washington has teamed up with SafeBuild Alliance and with many local construction companies, the Multnomah County’s health division and the Oregon Health Authority (OHA) to roll out “Reverse Overdose Oregon.” OHA’s campaign launched November 18 at Skanska’s offices as part of a statewide business-to-business effort to address the opioid epidemic through direct, comprehensive interventions.

The Oregon Health Authority (OHA) announced its new project to support Oregon employers in adopting opioid overdose response programs […]

December 2, 2019 |


On Oct. 29, industry expert judges and attendees picked the four winners of the Oregon Bioscience Association’s 2019 Research Fast Pitch and Company Pitch Fest competition. Entrants competed for more than $15,000 worth of cash and prizes, designed to further their study and commercialization potential. The presentations and voting happened at the Oregon Bio 2019: Innovating and Scaling for our Region’s Growth conference.

The winner was Sparrow Pharmaceuticals and its President, David Katz, Ph.D. Dr. Katz presented Sparrow’s […]

Innovative Cell Therapy Research Boosted by State Funds

November 13, 2019 –

An innovative new research project from UO’s Robert Guldberg has captured the attention of Oregon’s economic development agency Business Oregon and the UO’s Office of the Vice President for Research and Innovation.

Guldberg’s $1.2 million project, which zeroes in on one of the central challenges of the fast-growing cell therapy industry, is the first to tap into the University Innovation Research Fund. The new state fund is designed to support research at Oregon universities that drives innovation […]

November 14, 2019 |

Voice of Industry: Lisa Hale, CEO of Grace Bio-Labs, Part 2

After catching up recently with Lisa Hale, CEO of Grace Bio-Labs (see Part 1 of the conversation here),  Oregon Bio asked her a few more questions. Grace Bio-Labs is headquartered in Bend, Oregon. Having launched three decades ago, the company is now a globally recognized developer and manufacturer of tools for life science research, working to understand how protein and single-cell interactions are relevant in cancer detection.

As a voice of industry, we wanted to hear more about Grace […]

November 12, 2019 |


Two emerging bio companies and two rising-star researchers were chosen at Oregon Bio 2019: Innovating and Scaling for our Region’s Growth conference in Portland. Company Pitch Fest winner notes, “[We] appreciate the recognition this award provides for the potential impact of our efforts to deliver next generation steroid products with a substantially improved safety”

Industry expert judges and attendees picked the four winners of the Oregon Bioscience Association’s 2019 Research Fast Pitch and Company Pitch Fest competition this week. Entrants […]

October 31, 2019 |

In 2019, Edwards Lifesciences presented data showing that patients undergoing less-invasive, transcatheter aortic valve replacement procedures performed better after one year compared to those who had [...]

Gov. Gretchen Whitmer (D-Mich.) said Sunday that bidding between states for personal protective equipment (PPE) is creating problems as hospitals across the country are seeing depleted supplies amid t [...]

Louisiana Gov. John Bel Edwards (D) said Sunday that the state's health care system could become overwhelmed by early April.Edwards told ABC's "This Week" that coronavirus cases ar [...]

Amid Amgen's pricing war with Sanofi and Regeneron's Praluent, PCSK9 cholesterol fighter Repatha has been looking for a leg up in a wide-ranging clinical program involving dozens of trials. [...]

Pregnant women in New York City will not have to endure labor alone or remain isolated from their partners and families after Gov. Andrew Cuomo (D) announced an executive order on Saturday."In no [...]

AstraZeneca's SGLT2 diabetes med Farxiga is chugging ahead to a pioneering FDA approval in heart failure patents with or without Type 2 diabetes--a first in its class. As it awaits that nod, Farx [...]

After teasing positive top-line results last November, a deeper dive into Merck & Co. and Bayer's heart failure drug vericiguat helped kick off this year's scientific meeting of the Amer [...]

Sanofi is joining the array of companies pursuing a COVID-19 vaccine based on messenger RNA (mRNA), an experimental genetic technology intended to coax the body's cells into producing proteins th [...]